REGN here looks very solid at bottom of trend as well as structured support.
REGN is oversold on the daily, has hit an RSI floor of 35 that held in 2019 as it traded sideways, and is almost touching its 100 week MA. REGN has YoY has become more and more profitable, and is projected to grow at an annualized 11% over 5 years. My DCF calculations find it undervalued. This looks like an attractive buy point on a fundamental and technical...
This can be a good opportunity to jump in on REGN . The price performance has been declining significantly over the last months, yet the fundamental performance of REGN has proved to be resilient and pretty healthy. As the stock seems to hit a major support area , this can be the right opportunity to buy in. I am bullish on this one for the long term. I would set...
dip at strength support territory for scalp 494 461 449 2.88 R/R 7% upside scalp
Hi guys, hope you are well. Today we will be looking at Regeneron, hopefully at this point you understand the basics of Elliot wave and my diagram should be easily explainable. Wave 1 formed nicely with Wave 2 becoming an ending diagonal triangle in a corrective structure. The beginning of wave 3 has formed, and the structure is perfect for an investment...
Recently, NASDAQ:REGN has been in a downtrend. As supported by the technical indicators, there seems to be a potential trend reversal with a potential upside of 30% as evidenced by the oversold RSI level of <30 and a potential bullish divergence. A LONG initiated at or near $460 PS supported by near fib retracement level indicates 30% upside with the upside...
I am fairly new to analysis so take this with a grain of salt. But I believe REGN is in a downward channel and for the past two weeks or so has been hovering around two support levels. Due to the strong fundamentals of the company, and the fact that they beat earnings and have had only positive recent news. I believe that REGN is currently at a good buy point and...
Regeneron Pharmaceuticals (NASDAQ:REGN) has had a rough three months with its share price down 8.2%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. Specifically, we decided to...
Hello guys, it looks very interesting today REGENERON PHARMACEUTICALS INC. Everyone on the chart is waiting for questions if there are any comments. Good trade everyone
It's moving closeer to a low trend and the MACD histogram is negative.
Chart shows reversal has started. Might want to wait for confirmation. But I started a long trade (475-515). Long term position held for decade.
The main thesis is that $REGN pattern is similar to $ABBV; though it needed a catalyst for reversal. Today's news is the one + earnings next week. Target 1: $575 - short-term (earnings as catalyst) Target 2: $615 - mid-term (post-earnings till next earnings) Target 3: $650 - mid-year
Still holding the 0.5. Waiting the first 1-2 to start a position.
The last two long breakouts followed a spike in the RSI. The RSI spike this week. Maybe next week we will get the long breakout call.